COYA
Coya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.76
+4.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.95x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.00x
- Price / sales
- 13.92x
- Price / cash flow
- -0.01x
Enterprise value
- Enterprise value
- -$43.1B
- EV / sales
- -5370.81x
- EV / EBITDA
- 1951.45x
- EV / EBIT
- 1902.78x
- Market cap
- $111.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026